Registration Dossier

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1972
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Remarks:
limited documentation regarding test material as well as method, but clear description of results.

Data source

Reference
Reference Type:
other company data
Title:
Unnamed
Year:
1972
Report date:
1972

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Version / remarks:
the study pre-dates the relevant guideline
Deviations:
yes
Remarks:
reduced observation period; extreme doses
GLP compliance:
no
Remarks:
Study predates relevant regulations
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Hydrogen hydroxy[2-hydroxy-3-[(2-hydroxy-3-nitrobenzylidene)amino]-5-nitrobenzenesulphonato(3-)]chromate(1-), compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)
EC Number:
287-267-9
EC Name:
Hydrogen hydroxy[2-hydroxy-3-[(2-hydroxy-3-nitrobenzylidene)amino]-5-nitrobenzenesulphonato(3-)]chromate(1-), compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)
Cas Number:
85455-32-9
Molecular formula:
C13H7CrN3O10S.C11H25NO.H
IUPAC Name:
hydrogen hydroxy[2-hydroxy-3-[(2-hydroxy-3-nitrobenzylidene)amino]-5-nitrobenzenesulphonato(3-)]chromate(1-), compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)
Test material form:
solid
Specific details on test material used for the study:
Azomethinecolorant; Chromium complex, ammonium salt

Test animals

Species:
rat
Strain:
other: Gassner
Sex:
male/female
Details on test animals or test system and environmental conditions:
no data

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
CMC (carboxymethyl cellulose)
Remarks:
in water
Doses:
3200 - 6400 - 8000 - 10000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
Animals were treated once, observed for 7 days and necropsied. Observations were made on clinical signs, mortality as well as at necropsy.
Statistics:
not required

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 10 000 mg/kg bw
Based on:
test mat.
Mortality:
after 10000 mg/kg bw 1 animal died on day 4.
Clinical signs:
Immediately after application animals showed a squatting posture, accelerated, partly irregular, respiration and loss of hair in all groups. Symptom disappeared after several days in all groups.
Body weight:
no data
Gross pathology:
at 10000 mg/kg: loss of perirenal fat and greenish discoloration of kidneys
at 8000 mg/kg: loss of perirenal fat.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Even at the extreme doses above 3200 mg/kg bw only minor signs of toxicity were observed. The LD50 was clearly above 10000 mg/kg bw.
Executive summary:

After single oral gavage to rats at doses up to 10000 mg/kg the test material did cause only slight impairments of the general condition of the animals. One death was observed at the highest dose after 4 days. Clinical signs were limited to a squatting posture, accelerated, partly irregular respiration for few days after treatment. At necropsy loss of perirenal fat and discoloration of the kidneys was observed at 8000 mg/kg and above.

The LD50 was clearly above 10000 mg/kg bw.